Evidence map›Paper›PMID 39284867›Full record

ArticleScientific reports2024

Risk factor analysis and prediction model to establish recurrence or progression of non-functioning pituitary adenomas in men after transnasal sphenoidal surgery.

Jiansheng Zhong, Yuyang Chen, Mingyue Wang, Jun Li, Ziqi Li, Haixiang Li, Liangfeng Wei, Shousen Wang

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Reirradiation of recurrent brain tumors: a review by the ESTRO CNS Focus Group.Clinical and translational radiation oncology · 2027
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiansheng Zhong *Fujian Medical University, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 900 Hospital, Fuzhou, China.
Yuyang Chen *Fujian Medical University, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 900 Hospital, Fuzhou, China.
Mingyue WangDepartment of Pathology, Fuzhou 900 Hospital, Fuzhou, China.
Jun LiFujian Medical University, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 900 Hospital, Fuzhou, China.
Ziqi LiFujian Medical University, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 900 Hospital, Fuzhou, China.
Haixiang LiDepartment of Neurosurgery, Dongfang Hospital, Xiamen University, Fuzhou, China.
Liangfeng WeiFujian Medical University, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 900 Hospital, Fuzhou, China.
Shousen WangFujian Medical University, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 900 Hospital, Fuzhou, China. wshsen1965@fjmu.edu.cn.

Funding

the Fujian Provincial Science and Technology Program Science and Technology Innovation Platform Project 2022Y2017the Joint Logistics Medical Key Specialty Project LQZD-SW
6 · The paper itself

Abstract

This paper aims to analyze the risk factors for the recurrence or progression of non-functioning pituitary adenomas (NFPAs) in male patients after transnasal sphenoidal surgery and to develop a predictive model for prognosis. Clinical and follow-up data of 126 male patients with NFPAs treated by transnasal sphenoidal surgery from January 2011 to January 2021 in Fuzhou 900th Hospital were retrospectively analyzed. Lasso regression analysis was used to screen the best predictors, and the predictors were further screened by multivariate logistic regression analysis, and the nomogram prediction model was constructed. The performance of the model was verified by three aspects: discrimination, calibration and clinical utility by using the consistency index (C-index), receiver operating characteristic curve (ROC), calibration curve, clinical decision curve (DCA) and Clinical impact curve (CIC). Out of 126 cases, 7 (5.56%) showed postoperative tumor recurrence, and 18 (14.29%) exhibited postoperative residual regrowth (progression). Age (P = 0.024), maximum tumor diameter (P < 0.001), modified Knosp grade (P < 0.001), resection extent (P < 0.001), Ki67 (P < 0.001), pressure symptom (P < 0.001), Pre-op hypopituitarism (P = 0.048), Post-op new hypopituitarism (P = 0.017) showed significant differences among the recurrence group, the progression group, and the alleviation group. Three independent risk factors (Ki67, modified Knosp grade, and resection extent) affecting postoperative remission were used to construct a predictive model for long-term postoperative failure to remit. The C-index of the nomogram model was 0.823, suggesting that the model had a high discriminatory power, and the AUC of the area under the ROC curve was 0.9[95% CI (0.843, 0.958)]. A nomogram prediction model based on modified Knosp grading (grades 3B-4), resection extent (partial resection), and Ki-67 (≥ 3%) predicts the recurrence or progression of NFPAs in men after transnasal sphenoidal surgery.

Indexed as

AdenomaDisease ProgressionNeoplasm Recurrence, LocalNomogramsPituitary NeoplasmsAdultAgedHumansMaleMiddle AgedPrognosisRetrospective StudiesRisk FactorsROC CurveMale patients with pituitary adenomaNomogramPituitary adenomaPrognostic modelsTransnasal sphenoidal surgeryTumor recurrence or progression

Identifiers

PMID39284867
PMCPMC11405691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.